Beringea to Sell Pioneer Surgical Technology to RTI Biologics for $130 Mln
RTI Biologics, a provider of orthopedic and other biologic implants, said on Tuesday that it will buy Pioneer Surgical Technology from Beringea. Under terms of the merger agreement, RTI will pay $130 million in cash to acquire all outstanding stock of Pioneer. Based in Marquette, Michigan, Pioneer Surgical is a maker of products for the spine, biologics, orthopedics, and cardiothoracic markets.


